Send me a link:

*Text messaging rates may apply.

 Dow Down 0.18% Nasdaq Down 0.40%

Epizyme, Inc. (EPZM)

-NasdaqGS
32.58 Down 0.56(1.69%) 12:11PM EDT - Nasdaq Real Time Price
Prev Close:33.14
Open:33.25
Bid:32.46 x 100
Ask:32.54 x 100
1y Target Est:42.50
Beta:3.513
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:31.99 - 33.25
52wk Range:18.10 - 42.71
Volume:72,011
Avg Vol (3m):236,554
Market Cap:1.07B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EPZM

Comparison

Symbol% ChgMkt Cap
EPZMDown 1.69%1.07B
GSKDown 0.78%115.82B
NVSDown 0.92%212.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.93
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.81
Quarterly EPS Est (Jun-14) :-0.50
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops personalized therapeutics for patients with genetically defined cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback